Back to search
FDAFDA · Food and drugs·Recall number D-0982-2017

PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981

Published July 26, 2017 · Recall initiated: May 24, 2017

Summary

FDA records drug Class III recall D-0982-2017, published July 26, 2017 and initiated May 24, 2017. Recalling firm: Shionogi Inc.; Status: Terminated; Reported quantity: 455 bottles; Lot: Lot #: 5H66200103, Exp. June 2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Shionogi Inc.
Distributor
Nationwide
Lot
Lot #: 5H66200103, Exp. June 2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981 recalled?

Yes. FDA published recall D-0982-2017 on July 26, 2017. Reported hazard: Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

What should I do if I have this product?

Voluntary: Firm initiated · Letter